# Hyperpolarized MRSI in Ischemic Heart Disease: A Metabolic Investigation of the Heart Muscle

> **NCT06054516** · — · RECRUITING · sponsor: **Henrik Wiggers** · enrollment: 15 (estimated)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DIAGNOSTIC_TEST:** 13C-enriched pyruvate

## Key facts

- **NCT ID:** NCT06054516
- **Lead sponsor:** Henrik Wiggers
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-13
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06054516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06054516, "Hyperpolarized MRSI in Ischemic Heart Disease: A Metabolic Investigation of the Heart Muscle". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06054516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*